Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Oncology Letters|June 22, 2018
TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancerJoanna Huszno, Ewa GrzybowskaBiochimica Et Biophysica Acta|June 16, 2009
HAX-1: a multifunctional protein with emerging roles in human diseaseBengt Fadeel, Ewa GrzybowskaMedical Oncology (Northwood, London, England)|December 25, 2016
CTC clusters in cancer progression and metastasisAnna Fabisiewicz, Ewa GrzybowskaOncology Letters|January 25, 2019
BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survivalJoanna Huszno, Zofia Kołosza, Ewa GrzybowskaArchives of Biochemistry and Biophysics|February 8, 2002
Saccharomyces cerevisiae ferrochelatase forms a homodimerEwa Grzybowska, Monika Góra, Danuta Plochocka, et al.Oncotarget|August 17, 2016
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patientsKarolina Tecza, Jolanta Pamula-Pilat, Joanna Lanuszewska, et al.Archives of Medical Science : AMS|May 20, 2022
Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factorsJoanna Huszno, Zofia Kolosza, Jolanta Mrochem-Kwarciak, et al.Scientific Reports|April 3, 2020
Genetic 3'UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patientsJolanta Pamuła-Piłat, Karolina Tęcza, Magdalena Kalinowska-Herok, et al.Oncotarget|March 7, 2018
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patientsKarolina Tecza, Jolanta Pamula-Pilat, Joanna Lanuszewska, et al.Journal of Experimental & Clinical Cancer Research : CR|January 17, 2015
Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapyKarolina Tecza, Jolanta Pamula-Pilat, Zofia Kolosza, et al.Pageof 5